Kim, Byung Soo
Jo, Seong Jin
Youn, SangWoong
Reich, Kristian
Saadoun, Carine
Chang, Chia-Ling
Yang, Ya-Wen
Huang, Yu-Huei
Tsai, Tsen-Fang http://orcid.org/0000-0002-1498-1474
Funding for this research was provided by:
Janssen Pharmaceuticals
Article History
Received: 8 December 2022
Accepted: 23 February 2023
First Online: 26 September 2023
Declarations
:
: Byung Soo Kim has served as a scientific adviser, a clinical study investigator and/or a speaker for AbbVie, Astellas, Boehringer Ingelheim, Bristol Myers Squibb, Celltrion, Eli Lilly, Galderma, GlaxoSmithKline, Janssen, Kyowa Hakko Kirin, LEO Pharma, Novartis, Regeneron, Samsung, Sanofi and UCB. Seong-Jin Jo has conducted clinical trials for, acted as a consultant for, or received speaker’s honoraria from AbbVie, Boehringer Ingelheim, Bristol Myers Squibb, Daewoong, Janssen, LEO Pharma, Lilly, Novartis, Pfizer and Sanofi. SangWoong Youn served as a speaker for AbbVie, Cellgene, Eli Lilly, Janssen, LEO Pharma, Novartis and Pfizer organised psoriasis symposium or meetings, and has also performed phase III clinical trials sponsored by Janssen, Novartis, Boehringer Ingelheim, BMS, Eli Lilly, Kyowa Kirin and UCB and phase IV clinical trials sponsored by CKD Pharma, Janssen and LEO Pharma. Kristian Reich has served as a paid advisor and/or a paid speaker for and/or participated in clinical trials (site received patient fees, received fees if acting as a coordinating investigator) sponsored by AbbVie, Affibody, Almirall, Amgen, Biogen-Idec, Boehringer Ingelheim Pharma, Celgene, Covagen, Forward Pharma, Fresenius Medical Care, Galderma, GlaxoSmithKline, Janssen, Janssen-Cilag, Kyowa Kirin, Leo, Eli Lilly, Medac, Merck Sharp & Dohme, Miltenyi, Novartis, Ocean Pharma, Pfizer, Samsung Bioepis, Sanofi, Takeda, UCB Pharma, Valeant and Xenoport. Carine Saadoun, Chia-Ling Chang and Ya-Wen Yang are employees of Janssen Pharmaceutical Companies of Johnson & Johnson. Yu-Huei Huang has conducted clinical trials while serving as a principal investigator for AbbVie, Galderma, Eli Lilly, Janssen-Cilag Pharmaceutica, Novartis Pharmaceuticals Corporation and Pfizer and has received honoraria for serving as an advisory board member for and speaking fees from AbbVie, Celgene, Eli Lilly, Janssen-Cilag Pharmaceutica, Novartis Pharmaceuticals Corporation and Pfizer Limited. Tsen-Fang Tsai has conducted clinical trials or received honoraria for serving as a consultant for Abbvie, Boehringer Ingelheim, Bristol Myers Squibb, Celgene, Eli‐Lilly, Galderma, GSK, Janssen‐Cilag, Leo Pharma, Merck Sharp & Dohme, Novartis International, Pfizer, PharmaEssentia, Sanofi, and UCB Pharma.
: This article is based on previously conducted studies (VOYAGE 1 and VOYAGE 2) and does not contain any new studies with human participants performed by any of the authors. Both VOYAGE 1 and VOYAGE 2 were conducted in accordance with ethical principles that have their origin in the Declaration of Helsinki and are consistent with Good Clinical Practices. The study protocols were approved by institutional review boards or independent ethics committees. All participants provided written informed consent.